Health Care Equipment & Services

CEO Jamie Reynoso sells 2,006 Clover Health shares at $4.63 – a routine tax‑cover sale amid rising insider activity and a 70% YTD gain.

CEO Nikolas Stengle sells 20,677 shares of Brookdale Senior Living, raising questions about insider confidence amid the company’s 10.92% monthly decline.

OMADA insiders’ RSU buys signal board confidence, boosting investor optimism for future growth and product launches.

Waystar CEO Matthew Hawkins executes a Rule 144 buy‑sell plan, buying at $4.14 and selling at $26.23—showing strategic liquidity and confidence in the stock’s upside.

Inside SOPHiA Genetics’ October 5 insider sales: a tax‑planning move, not panic, showing exec confidence and long‑term growth outlook.

Alignment Healthcare’s recent insider selling shows tax‑driven moves, not a crisis. Learn how the company’s continuous‑care platform and solid pipeline could still offer a margin of safety for value‑focused investors.

GIC’s recent sell‑offs of MEDLINE Inc. shares signal routine portfolio rebalancing, not a downgrade, underscoring the company’s solid fundamentals and investor confidence.

SI‑BONE insider trades: Michael Piestysky’s October sell‑to‑cover trades reveal routine RSU vesting, not bearish signals. Investors see stable insider activity amid strong growth prospects.

Tansey Casey’s fresh 733‑share purchase of Shoulder Innovations signals insider confidence in its tech‑pivot, urging investors to re‑evaluate the stock’s undervaluation and potential upside.

Insider buys at Shoulder Innovations signal board confidence amid a tech pivot—watch RSU‑driven gains and partnership wins for a potential rebound.